Effect of continuation of intensive phase on poor responders of antituberculosis treatment on morbidity and mortality in central nervous system tuberculosis (CNS-TB)

Ravindra Inaththappulige,Chulika Makawita,Hasini Munasinghe,Kasun Udenike,Ishani Rajapakshe,Sameera Wijayawardhana,Tharuka Herath,Amitha Fernando,Bimsara Senanayake

doi:10.1016/j.jns.2023.121132

Effect of continuation of intensive phase on poor responders of antituberculosis treatment on morbidity and mortality in central nervous system tuberculosis (CNS-TB)

Ravindra Inaththappulige, Chulika Makawita + Show 7 more

https://doi.org/10.1016/j.jns.2023.121132

Copy DOI

Export

Save

Cite

Journal: Journal of the Neurological Sciences

Publication Date: Dec 1, 2023

#Central Nervous System Tuberculosis #Morbidity In Tuberculosis #Mortality In Tuberculosis #System Tuberculosis #Intensive Phase #Antituberculosis Treatment #Poor Responders #Central Nervous System #Nervous System

Abstract
Full-Text
Similar Papers

Abstract

Listen

Effect of continuation of intensive phase on poor responders of antituberculosis treatment on morbidity and mortality in central nervous system tuberculosis (CNS-TB)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of the Neurological Sciences

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Effect of continuation of intensive phase on poor responders of antituberculosis treatment on morbidity and mortality in central nervous system tuberculosis (CNS-TB)